NeuroPace, Inc. (NPCE)
13.99
-0.04
(-0.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.99
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Shareholders Equity (Quarterly) : 11.88M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.88M |
| March 31, 2026 | 14.45M |
| December 31, 2025 | 19.03M |
| September 30, 2025 | 18.52M |
| June 30, 2025 | 19.44M |
| March 31, 2025 | 24.27M |
| December 31, 2024 | 8.013M |
| September 30, 2024 | 9.823M |
| June 30, 2024 | 9.885M |
| March 31, 2024 | 14.34M |
| December 31, 2023 | 20.65M |
| September 30, 2023 | 16.36M |
| Date | Value |
|---|---|
| June 30, 2023 | 21.23M |
| March 31, 2023 | 27.49M |
| December 31, 2022 | 34.78M |
| September 30, 2022 | 43.41M |
| June 30, 2022 | 52.90M |
| March 31, 2022 | 62.82M |
| December 31, 2021 | 73.50M |
| September 30, 2021 | 81.71M |
| June 30, 2021 | 88.67M |
| March 31, 2021 | -15.01M |
| December 31, 2020 | -6.41M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 130.39M |
| CVRx, Inc. | 19.95M |
| Accuray, Inc. | 41.70M |
| Orthofix Medical, Inc. | 429.18M |
| ResMed, Inc. | 6.585B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.99M |
| Total Liabilities (Quarterly) | 85.11M |
| Debt to Equity Ratio | 5.885 |
| Current Ratio | 4.944 |
| Net Debt Paydown Yield | 0.12% |